Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes with ASCVDca-mccqe1ca-rcpsc-im

A 52-year-old man with type 2 diabetes (HbA1c 8.3 percent), BMI 35 kg/m², and established atherosclerotic cardiovascular disease is already on metformin and a statin. According to Diabetes Canada, which additional antihyperglycaemic agent provides the greatest cardiovascular benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.